During the past decade, Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" #1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" are "Epilepsy, Partial Seizures" (2 trials), "Epilepsy" (1 trials), "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials), "Multiple Sclerosis" (1 trials) and "Relapsing-Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" in a lesser frequency.

Most popular intervention types in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Eslicarbazepine Acetate" (1 trials), "Fingolimod" (1 trials), "Fingolimod Placebo" (1 trials) and "Ocrelizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".